Evaluating Connected Watches to Help People 65 and Older Stop Benzodiazepines Successfully

What this Trial Is About

Researchers are investigating whether using a connected watch can help people aged 65 and older successfully stop or reduce their use of benzodiazepines over six months. Benzodiazepines are commonly used in older adults but carry risks when used long-term. This study compares the usual method of gradual withdrawal with an approach that includes monitoring sleep quality and physical activity through a connected watch. The study plans to enroll 100 participants, divided equally into two groups, identified during a one-year period from geriatric consultations or hospital stays. Participants in both groups will follow a gradual benzodiazepine reduction plan, decreasing their dose every two weeks over six months. Both groups will receive motivational phone calls twice a month. The intervention group will also use a connected watch that provides feedback on their sleep and activity levels, aiming to support their withdrawal process. Throughout the study, participants will be monitored through regular phone calls to encourage adherence. The main outcome measured is the success in stopping or reducing benzodiazepine use after six months. The study is open-label and randomized, with no blinding. Participants must have unassisted mobility, sufficient cognitive function, and access to a smartphone or tablet with internet. The total involvement lasts six months with ongoing support and evaluation.

Can Connected Devices Increase the Success Rate of Benzodiazepine Withdrawals in the Elderly?